跳至主要内容
临床试验/NCT06646406
NCT06646406已完成不适用

Evaluation of a Multilevel Intervention on Adult COVID-19 and Influenza Vaccination Rate

Mayo Clinic3 个研究点 分布在 1 个国家目标入组 114,165 人开始时间: 2024年10月21日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Mayo Clinic
入组人数
114,165
试验地点
3
主要终点
Influenza vaccine uptake

研究概览

简要总结

The study will test two tactics to improve uptake of two vaccines in adults. The vaccines prevent COVID-19 and influenza. Both are common and harmful. Most adults do not get either vaccine. This is despite strong recommendations that all adults get both vaccines.

The study will involve adult patients at eight Mayo Clinic primary care practices in Rochester and Kasson. The study will test the two tactics together. Four clinics will get the two tactics. The other four clinics will not. The study will randomly assign the two tactics to the clinics. One tactic is to send a letter by US mail to the patient. The letter will state strong recommendations on getting both vaccines now. It will tell patients how to get the vaccines now. The second tactic is to send monthly emails to clinicians. It will remind them to use every visit to vaccinate patients against COVID-19 and influenza. The study will compare the uptake of the two vaccines after six months in the clinics with and without the two tactics.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients 19 years and older
  • Patients empaneled to 1 of 8 adult primary care practices as of September 2024

排除标准

  • Patients 18 years or younger
  • Patients not empaneled to 1 of 8 adult primary care practices as of September 2024

结局指标

主要结局

Influenza vaccine uptake

时间窗: 9 months

Rates of at least one dose of single licensed 2024-2025 trivalent influenza vaccine among adult patients at eight Mayo Clinic primary care practices

COVID-19 vaccine uptake

时间窗: 7.5 months

Rates of at least one dose of single licensed 2024-2025 COVID-19 vaccine among adult patients at eight Mayo Clinic primary care practices

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Lila J. Rutten

Professor of Health Services Research; Chair, Division of Epidemiology, Department of Quantitative Health Sciences

Mayo Clinic

研究点 (3)

Loading locations...

相似试验